Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Total 13F shares
-
74,207,296
-
Share change
-
+731,512
-
Total reported value
-
$12,840,473,582
-
Put/Call ratio
-
64%
-
Price per share
-
$173.04
-
Number of holders
-
348
-
Value change
-
+$248,693,042
-
Number of buys
-
206
-
Number of sells
-
117
Institutional Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2020
As of 31 Dec 2020,
NovoCure Ltd - Common Stock (NVCR) was held by
348 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
74,207,296 shares.
The largest 10 holders included
FMR LLC, BAILLIE GIFFORD & CO, Capital International Investors, VANGUARD GROUP INC, Capital World Investors, BlackRock Inc., STATE STREET CORP, CREDIT SUISSE AG/, MORGAN STANLEY, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
348
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.